News Items from UNC Greensboro

Dr. Christopher Kepley (JSNN) received funding from the North Carolina Biotechnology Center for the project “Identification and validation of novel therapies for the inhibition of atherosclerotic plaque lesions.” Atherosclerosis is a chronic inflammatory disease affecting arterial blood vessels. Treatment of the disease is extremely expensive and contributes to the rising cost of healthcare within the US,” the abstract notes. “The goal of this proposal is to test a battery of variously derivatized fullerenes for their ability to dually inhibit foam cell formation and prevent and/or reverse atherosclerotic plaque lesions in vivo.”

Share This